$0.1600
-0.02-11.16%
al cierre: -
$0.1664
0.006404.00%
After hour: 7:59 PM EDT
Comments
Loading...
Adaptimmune Therapeutics Actividad de operaciones con información privilegiada
ADAPNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Adaptimmune Therapeutics. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Adaptimmune Therapeutics.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Adaptimmune Therapeutics PLC los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El septiembre 3, 2025, Gavin Wood, la empresa CHIEF FINANCIAL OFFICER sold 96K acciones por $0.01 cada una.
- El agosto 29, 2025, William Charles Bertrand, la empresa CHIEF OPERATING OFFICER sold 207K acciones por $0.01 cada una.
- El agosto 19, 2025, Ali Behbahani, la empresa - sold 19.5M acciones por $0.01 cada una.
Estadísticas de propiedad de Adaptimmune Therapeutics PLC
Acciones en circulación
265.052M
Acciones en manos de personas con información privilegiada
32.196M
Porcentaje de acciones en manos de personas con información privilegiada
2.02%
Acciones en manos de instituciones
922.920K
Porcentaje de acciones en manos de instituciones
0.35%
Sep 03, 2025 | CHIEF FINANCIAL OFFICER | -96.00K | $0.01 | -$950.40 | SELL | -100.00% | 0.00 | Sep 02 | ||
Aug 29, 2025 | CHIEF OPERATING OFFICER | -207.00K | $0.01 | -$2.09K | SELL | -17.35% | 986.35K | Aug 28 | ||
Aug 19, 2025 | — | -19.50M | $0.01 | -$229.17K | SELL | -100.00% | 0.00 | Aug 15 - Aug 18 | ||
Jul 30, 2025 | 10% OWNER | -64.05M | $0.11 | -$6.89M | SELL | -38.96% | 100.37M | Jul 28 - Jul 30 | ||
Jan 17, 2025 | CHIEF MEDICAL OFFICER | -5.58K | $0.58 | -$3.24K | SELL | -42.65% | 7.51K | Jan 17 | ||
Jan 17, 2025 | CHIEF PATIENT SUPPLY OFFICER | -5.58K | $0.58 | -$3.24K | SELL | -42.65% | 7.51K | Jan 17 | ||
Jan 17, 2025 | CHIEF OPERATING OFFICER | -5.58K | $0.58 | -$3.24K | SELL | -42.65% | 7.51K | Jan 17 | ||
Jan 17, 2025 | CHIEF EXECUTIVE OFFICER | -30.60K | $0.58 | -$17.77K | SELL | -40.84% | 44.33K | Jan 17 | ||
Jan 15, 2025 | CHIEF EXECUTIVE OFFICER | -59.57K | $0.58 | -$34.64K | SELL | -58.89% | 41.58K | Jan 13 - Jan 15 | ||
Jan 15, 2025 | CHIEF COMMERCIAL OFFICER | -12.99K | $0.57 | -$7.47K | SELL | -41.36% | 18.42K | Jan 15 | ||
Jan 15, 2025 | CHIEF MEDICAL OFFICER | -22.20K | $0.58 | -$12.92K | SELL | -61.74% | 13.76K | Jan 13 - Jan 15 | ||
Jan 15, 2025 | CHIEF PATIENT SUPPLY OFFICER | -19.54K | $0.58 | -$11.36K | SELL | -58.69% | 13.76K | Jan 13 - Jan 15 | ||
Jan 15, 2025 | CHIEF OPERATING OFFICER | -19.54K | $0.58 | -$11.36K | SELL | -58.69% | 13.76K | Jan 13 - Jan 15 | ||
Jun 18, 2024 | CHIEF COMMERCIAL OFFICER | -24.53K | $0.93 | -$22.81K | SELL | -39.05% | 38.29K | Jun 18 | ||
Jan 17, 2024 | CHIEF EXECUTIVE OFFICER | -39.38K | $0.70 | -$27.59K | SELL | -46.76% | 44.85K | Jan 16 - Jan 17 | ||
Jan 17, 2024 | CHIEF MEDICAL OFFICER | -20.56K | $0.69 | -$14.11K | SELL | -51.64% | 19.26K | Jan 16 - Jan 17 | ||
Jan 17, 2024 | CHIEF PATIENT SUPPLY OFFICER | -22.80K | $0.70 | -$15.89K | SELL | -54.52% | 19.02K | Jan 16 - Jan 17 | ||
Jan 17, 2024 | CHIEF OPERATING OFFICER | -23.59K | $0.70 | -$16.42K | SELL | -53.87% | 20.20K | Jan 16 - Jan 17 | ||
Jan 12, 2024 | CHIEF MEDICAL OFFICER | -11.81K | $0.85 | -$10.02K | SELL | -49.93% | 11.84K | Jan 11 - Jan 12 | ||
Jan 12, 2024 | CHIEF OPERATING OFFICER | -9.23K | $0.85 | -$7.81K | SELL | -53.96% | 7.87K | Jan 11 - Jan 12 | ||
Jan 12, 2024 | CHIEF EXECUTIVE OFFICER | -29.20K | $0.85 | -$24.73K | SELL | -52.53% | 26.39K | Jan 11 - Jan 12 | ||
Jan 12, 2024 | CHIEF PATIENT SUPPLY OFFICER | -9.23K | $0.85 | -$7.81K | SELL | -53.96% | 7.87K | Jan 11 - Jan 12 | ||
Sep 01, 2023 | CHIEF EXECUTIVE OFFICER | -2.40K | $0.78 | -$1.87K | SELL | -41.06% | 3.45K | Sep 01 | ||
Aug 01, 2023 | CHIEF PATIENT SUPPLY OFFICER | -3.10K | $0.91 | -$2.80K | SELL | -39.62% | 4.72K | Aug 01 | ||
Jul 10, 2023 | DIRECTOR | -47.70K | $0.91 | -$43.45K | SELL | -38.86% | 75.06K | Jul 10 | ||
Jun 27, 2023 | CHIEF EXECUTIVE OFFICER | -2.33K | $0.92 | -$2.15K | SELL | -39.87% | 3.52K | Jun 27 | ||
Jan 31, 2023 | CHIEF COMMERCIAL OFFICER | -11.89K | $1.87 | -$22.23K | SELL | -37.84% | 19.54K | Jan 31 | ||
Jan 17, 2023 | CHIEF PATIENT SUPPLY OFFICER | -4.44K | $1.86 | -$8.25K | SELL | -37.94% | 7.26K | Jan 17 | ||
Jan 17, 2023 | CHIEF OPERATING OFFICER | -4.44K | $1.86 | -$8.25K | SELL | -37.94% | 7.26K | Jan 17 | ||
Jan 17, 2023 | CHIEF MEDICAL OFFICER | -2.16K | $1.86 | -$4.01K | SELL | -38.21% | 3.49K | Jan 17 | ||
Jan 17, 2023 | CHIEF EXECUTIVE OFFICER | -10.06K | $1.86 | -$18.69K | SELL | -42.96% | 13.35K | Jan 17 | ||
Jan 12, 2023 | CHIEF OPERATING OFFICER | -8.82K | $1.72 | -$15.20K | SELL | -52.05% | 8.12K | Jan 11 - Jan 12 | ||
Jan 12, 2023 | CHIEF PATIENT SUPPLY OFFICER | -8.82K | $1.72 | -$15.20K | SELL | -52.05% | 8.12K | Jan 11 - Jan 12 | ||
Jan 12, 2023 | CHIEF MEDICAL OFFICER | -11.29K | $1.72 | -$19.42K | SELL | -48.09% | 12.19K | Jan 11 - Jan 12 | ||
Jan 12, 2023 | CHIEF EXECUTIVE OFFICER | -31.80K | $1.72 | -$54.79K | SELL | -56.11% | 24.88K | Jan 11 - Jan 12 | ||
Jan 04, 2023 | CHIEF OPERATING OFFICER | -3.58K | $1.69 | -$6.07K | SELL | -38.27% | 5.78K | Jan 04 | ||
Jan 04, 2023 | CHIEF PATIENT SUPPLY OFFICER | -1.10K | $1.69 | -$1.86K | SELL | -38.94% | 1.73K | Jan 04 | ||
Jan 04, 2023 | CHIEF MEDICAL OFFICER | -876.00 | $1.69 | -$1.48K | SELL | -39.16% | 1.36K | Jan 04 | ||
Jan 04, 2023 | CHIEF EXECUTIVE OFFICER | -5.07K | $1.69 | -$8.59K | SELL | -43.34% | 6.63K | Jan 04 | ||
Sep 01, 2022 | CHIEF EXECUTIVE OFFICER | -2.54K | $1.97 | -$4.99K | SELL | -43.34% | 3.32K | Sep 01 | ||
Aug 01, 2022 | CHIEF PATIENT SUPPLY OFFICER | -2.98K | $1.77 | -$5.29K | SELL | -38.18% | 4.83K | Aug 01 | ||
Aug 01, 2022 | CHIEF COMMERCIAL OFFICER | -21.04K | $1.77 | -$37.31K | SELL | -37.66% | 34.82K | Aug 01 | ||
Jul 05, 2022 | CHIEF PATIENT SUPPLY OFFICER | -1.97K | $1.68 | -$3.31K | SELL | -38.86% | 3.10K | Jul 05 | ||
Jun 27, 2022 | CHIEF EXECUTIVE OFFICER | -2.56K | $1.63 | -$4.18K | SELL | -43.78% | 3.29K | Jun 27 | ||
May 23, 2022 | CHIEF FINANCIAL OFFICER | 39.00K | $0.29 | $11.33K | BUY | 68.42% | 96.00K | May 20 | ||
Jan 18, 2022 | CHIEF OPERATING OFFICER | -4.37K | $3.19 | -$13.94K | SELL | -37.32% | 7.34K | Jan 18 | ||
Jan 18, 2022 | CHIEF PATIENT SUPPLY OFFICER | -4.37K | $3.19 | -$13.94K | SELL | -37.32% | 7.34K | Jan 18 | ||
Jan 18, 2022 | CHIEF MEDICAL OFFICER | -2.12K | $3.19 | -$6.77K | SELL | -37.54% | 3.53K | Jan 18 | ||
Jan 18, 2022 | CHIEF EXECUTIVE OFFICER | -11.10K | $3.19 | -$35.42K | SELL | -47.40% | 12.31K | Jan 18 | ||
Jan 13, 2022 | CHIEF OPERATING OFFICER | -6.02K | $3.55 | -$21.38K | SELL | -61.58% | 3.75K | Jan 11 - Jan 12 | ||
Jan 13, 2022 | CHIEF PATIENT SUPPLY OFFICER | -4.85K | $3.55 | -$17.22K | SELL | -73.48% | 1.75K | Jan 11 - Jan 12 | ||
Jan 13, 2022 | CHIEF MEDICAL OFFICER | -4.62K | $3.55 | -$16.44K | SELL | -76.98% | 1.38K | Jan 11 - Jan 12 | ||
Jan 13, 2022 | CHIEF EXECUTIVE OFFICER | -17.41K | $3.55 | -$61.88K | SELL | -83.84% | 3.36K | Jan 11 - Jan 12 | ||
Jan 05, 2022 | CHIEF OPERATING OFFICER | -3.49K | $4.06 | -$14.18K | SELL | -37.27% | 5.87K | Jan 04 | ||
Jan 05, 2022 | CHIEF PATIENT SUPPLY OFFICER | -1.07K | $4.06 | -$4.35K | SELL | -37.88% | 1.75K | Jan 04 | ||
Jan 05, 2022 | CHIEF MEDICAL OFFICER | -849.00 | $4.06 | -$3.45K | SELL | -37.95% | 1.39K | Jan 04 | ||
Jan 05, 2022 | CHIEF EXECUTIVE OFFICER | -5.53K | $4.06 | -$22.48K | SELL | -47.27% | 6.17K | Jan 04 | ||
Aug 02, 2021 | CHIEF PATIENT SUPPLY OFFICER | -2.94K | $3.58 | -$10.54K | SELL | -37.62% | 4.87K | Aug 02 | ||
Jul 02, 2021 | CHIEF OPERATING OFFICER | -4.38K | $4.26 | -$18.66K | SELL | -37.38% | 7.33K | Jul 02 | ||
Jul 02, 2021 | CHIEF PATIENT SUPPLY OFFICER | -1.91K | $4.26 | -$8.13K | SELL | -37.56% | 3.17K | Jul 02 | ||
Jun 28, 2021 | CHIEF EXECUTIVE OFFICER | -2.79K | $4.37 | -$12.21K | SELL | -47.74% | 3.06K | Jun 28 | ||
Jun 03, 2021 | DIRECTOR | 12.60K | $0.79 | $9.95K | BUY | 17.85% | 83.18K | Jun 01 | ||
Jan 19, 2021 | CHIEF MEDICAL OFFICER | -2.11K | $5.67 | -$11.97K | SELL | -37.36% | 3.54K | Jan 19 | ||
Jan 19, 2021 | CHIEF PATIENT SUPPLY OFFICER | -4.36K | $5.67 | -$24.71K | SELL | -37.24% | 7.35K | Jan 19 | ||
Jan 19, 2021 | CHIEF EXECUTIVE OFFICER | -9.88K | $5.67 | -$56.01K | SELL | -42.20% | 13.53K | Jan 19 | ||
Jan 12, 2021 | CHIEF OPERATING OFFICER | -2.23K | $6.15 | -$13.74K | SELL | -37.22% | 3.77K | Jan 12 | ||
Jan 12, 2021 | CHIEF PATIENT SUPPLY OFFICER | -1.06K | $6.15 | -$6.51K | SELL | -37.45% | 1.77K | Jan 12 | ||
Jan 12, 2021 | CHIEF MEDICAL OFFICER | -841.00 | $6.15 | -$5.17K | SELL | -37.59% | 1.40K | Jan 12 | ||
Jan 12, 2021 | CHIEF EXECUTIVE OFFICER | -2.71K | $6.15 | -$16.65K | SELL | -42.28% | 3.69K | Jan 12 | ||
Jan 05, 2021 | CHIEF PATIENT SUPPLY OFFICER | -1.06K | $5.33 | -$5.67K | SELL | -37.70% | 1.76K | Jan 04 | ||
Jan 05, 2021 | CHIEF OPERATING OFFICER | -3.50K | $5.33 | -$18.64K | SELL | -37.37% | 5.86K | Jan 04 | ||
Jan 05, 2021 | CHIEF MEDICAL OFFICER | -845.00 | $5.33 | -$4.50K | SELL | -37.77% | 1.39K | Jan 04 | ||
Jan 05, 2021 | CHIEF EXECUTIVE OFFICER | -4.97K | $5.33 | -$26.46K | SELL | -42.44% | 6.74K | Jan 04 | ||
Dec 16, 2020 | — | 24.00K | $0.69 | $16.55K | PURCHASE | 72.73% | 57.00K | Dec 14 | ||
Dec 15, 2020 | — | 207.00K | $0.69 | $143.82K | PURCHASE | 266.04% | 284.81K | Dec 14 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.